Plain-English translation of NCT07374289 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This study doesn't follow the usual testing phases β it may be an observational study or a different type of research.
This trial is testing a life-saving procedure called ECPR (extracorporeal cardiopulmonary resuscitation), which uses a portable heart-lung machine to support patients who have suffered a cardiac arrest and aren't responding to standard CPR. The study compares two approaches: starting the machine support on scene (at home or in the ambulance) versus waiting to start it at the hospital. The goal is to see if starting earlier saves more lives and helps patients recover better brain function.
Most patients who have sudden cardiac arrest and don't respond quickly to CPR don't survive. Research shows this treatment can help some of these patients, but the faster it starts, the better the chances of survival and recovery. This trial wants to know if bringing the machine to the patient β instead of transporting them first β can save more lives.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
If you qualify and are resuscitated, you will receive emergency heart-lung machine support either at the scene (if a mobile team can reach you quickly) or at the hospital emergency department. The medical team will decide which approach is best based on where you collapsed and how far away the hospital is. After stabilization, you will receive ongoing hospital care and follow-up to track your recovery and brain function over time.
AI-generated summary from trial data Β· Jun 28, 2026 Β· Not medical advice
Czechia